Table of Contents Table of Contents
Previous Page  57 / 220 Next Page
Information
Show Menu
Previous Page 57 / 220 Next Page
Page Background

Validation of a LC-MS/MS method of Analysis of Nicotinic acid and Nicotinamide in infant formula and adult

nutritional samples

___________________________________________________________

Copyright © 2012 Silliker, Inc.

17

The inter-day precision of the total niacin estimation in replicates (n=6 except NIST SRM with

n=4) on two days by the method in the SPIFAN samples in terms of % RSD varied in the range of

3.5% to 6.0%. The inter-day precision was slightly higher than 5% specified in the SMPR in some

of the samples though the value presented in the study are for the inter-day precision (Tables 3

and 4).

Spike Recovery Evaluation in SPIFAN Sample:

Spike Recovery of nicotinic acid as well as nicotinamide was evaluated in a SPIFAN

sample (Child Formula powder) at three different concentrations. . The summary of the

spike recovery results is presented in the following Table.

Table 5: Spike recovery evaluation of nicotinic acid and nicotinamide in a SPIFAN

Sample at different concentrations.

Average % Spike Recovery (n = 3)

Spike amount mcg/100g of the

reconstituted sample

Spike Level -->

250 (n=3)

500 (n=3)

1000 (n=3)

Nicotinic acid

99.5

99.5

99.5

Nicotinamide

99.4

99.4

99.4

Total Niacin

99.5

99.5

99.5

Child Formula powder sample was analyzed in replicates

wth and without spikes of different concentrations of

nicotinic acid as well as nicotinamide and their spike

recovery was estimated.

The % spike recovery of the nicotic acid and nicotinamide at all the concentrations

studied was found to be within 99.4 - 99.5%.

LOD / LOQ

Determination of the Method

The LOD and LOQ of the method were determined by replicate analysis of one of the

SPIFAN sample (

Adult Nutritional Powder Milk Protein based)

.

The sample was

analyzed in replicates (n=3) on multiple days (2 days) (total n=6). LOD & LOQ are calc

by 3*Stdev and 10*Stdev for total vitamin B3 (niacin) and the result are summarized in

the following Table 6.

VALIDATION REPORT

FOR ERP USE ONLY

DO NOT DISTRIBUTE